Replimune competitors and similar companiesClear all
3sbio's competitors and similar companies include Kyowa Kirin, Acerta Pharma and Clovis Oncology.
 Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. |  Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. | |||
Founding Date | Founding Date 1993 | Founding Date 2008 | Founding Date 2013 | Founding Date 2009 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Shenyang, CN HQ | Locations South San Francisco, US HQ Oss, NL Oss, NL | ||
Employees | Employees 5,2325% decrease | Employees 5,752 | Employees 197 | Employees 4843% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 11.2 b | Valuation ($) N/A | Valuation ($) 10.6 m |
Employee Rating | Employee Rating 3 | Employee Rating N/A | Employee Rating 3.5 | Employee Rating 3.8 |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥6.4b (FY, 2021) | Revenue (est.) ¥398.4b (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $148.8m (FY, 2021) |
Cost of goods | Cost of goods ¥777.3m (FY, 2021) | Cost of goods ¥68.4b (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥5.7b (FY, 2021) | Gross profit ¥331.6b (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income ¥1.6b (FY, 2021) | Net income ¥53.6b (FY, 2022) | Net income N/A | Net income ($264.5m) (FY, 2021) |
Funding | ||||
Total funding raised | Total funding raised $ 15.2m | Total funding raised N/A | Total funding raised $ 60m | Total funding raised $ 357m |
For sources of this data, please see the company profile
View company profiles
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,752
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View companyClovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View company